Trial · NCT01677910
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Treatment Period | STARTED | Placebo | 45 | |
| Double-Blind Treatment Period | STARTED | 250 mg Telotristat Etiprate | 45 | |
| Double-Blind Treatment Period | STARTED | 500 mg Telotristat Etiprate | 45 | |
| Double-Blind Treatment Period | STARTED | Telotristat Etiprate Open-Label Extension | 0 | |
| Double-Blind Treatment Period | COMPLETED | Placebo | 38 | |
| Double-Blind Treatment Period | COMPLETED | 250 mg Telotristat Etiprate | 42 | |
| Double-Blind Treatment Period | COMPLETED | 500 mg Telotristat Etiprate | 38 | |
| Double-Blind Treatment Period | COMPLETED | Telotristat Etiprate Open-Label Extension | 0 | |
| Double-Blind Treatment Period | NOT COMPLETED | Placebo | 7 | |
| Double-Blind Treatment Period | NOT COMPLETED | 250 mg Telotristat Etiprate | 3 | |
| Double-Blind Treatment Period | NOT COMPLETED | 500 mg Telotristat Etiprate | 7 | |
| Double-Blind Treatment Period | NOT COMPLETED | Telotristat Etiprate Open-Label Extension | 0 | |
| Open-Label Extension Period (OLE) | STARTED | Placebo | 0 | |
| Open-Label Extension Period (OLE) | STARTED | 250 mg Telotristat Etiprate | 0 | |
| Open-Label Extension Period (OLE) | STARTED | 500 mg Telotristat Etiprate | 0 | |
| Open-Label Extension Period (OLE) | STARTED | Telotristat Etiprate Open-Label Extension | 115 | |
| Open-Label Extension Period (OLE) | COMPLETED | Placebo | 0 | |
| Open-Label Extension Period (OLE) | COMPLETED | 250 mg Telotristat Etiprate | 0 | |
| Open-Label Extension Period (OLE) | COMPLETED | 500 mg Telotristat Etiprate | 0 | |
| Open-Label Extension Period (OLE) | COMPLETED | Telotristat Etiprate Open-Label Extension | 79 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01677910/flow